Fig. 3
From: Patient-reported outcomes in urticarial vasculitis treated with omalizumab: case report
UAS7, CU-Q2oL and UCT scores over time. Data are expressed as scores in Y axis, while time is expressed in a monthly scale on X axis. (A) UAS7, CU-Q2oL and UCT scores during treatment with Omalizumab. For CU-Q2oL, each of the six domains are represented separately (functioning, sleep, itching/embarrassment, mental status, swelling/eating and limits looks). Omalizumab doses received are depicted as purple circles. (B) UAS7 scores during follow-up after treatment with Omalizumab. UAS7, Urticaria Activity Score 7; CU-Q2oL, Chronic Urticaria Quality of Life; UCT, Urticaria Control Test